Biomarker ID | 1075 |
PMID | 23431474 |
Year | 2013 |
Biomarker | Methylation Status of APC |
Biomarker Basis | Methylation Based |
Biomolecule | Methylation |
Source | Tissue |
Subjects | Humans |
Regulation | Hypermethylated in early stages of PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways include: Pathways in cancer, Signal transduction, Irinotecan pathway, Actin cytoskeleton regulation, Apoptosis |
Experiment | Stage 1 & 2 Vs Stage 3 & 4 |
Type of Biomarker | Prognostic |
Cohort | 27 patients with Prostate Cancer (18 paraffin-embedded blocks of cancer patients who under- went radical prostatectomy and 9 patients who under-went transutheral resection of prostate (TURP) and 24 patients with Benign Prostatic Hyperplasia (BPH) were chosen for the study. [20 patients in Stage 1 and 2 , and 7 Patients in Stage 3 and 4] |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.049 |
Method Used | NA |
Clinical | No |
Remarks | All Patients were taken from Pakistani Origin |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |